Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02108756 | Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding | ||
| NCT03847246 | Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers | ||
| NCT06388759 | TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients | ||
| NCT06748079 | A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease | ||
| NCT06569524 | Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) | ||
| NCT06202261 | A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer | ||
| NCT06702618 | Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer | ||
| NCT05051930 | A Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT05405439 | To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer | ||
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | ||
| NCT06585059 | Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers | ||
| NCT05353179 | Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers | ||
| NCT04355520 | A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer | ||
| NCT06760182 | Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis | ||
| NCT04623333 | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer | ||
| NCT06725641 | Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics) | ||
| NCT06897579 | Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer | ||
| NCT05998941 | A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer | ||
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT07047365 | TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT05011019 | A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis | ||
| NCT06165822 | A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets | ||
| NCT06146751 | A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus | ||
| NCT04925141 | A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) | ||
| NCT06948539 | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors | ||
| NCT05862337 | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. | ||
| NCT06700395 | A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma | ||
| NCT06326671 | A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot) | ||
| NCT04975204 | A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT05987358 | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. | ||
| NCT07011186 | A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies | ||
| NCT04080843 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | ||
| NCT04523285 | A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics | ||
| NCT06469879 | A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients | ||
| NCT05800106 | A Bioequivalence Study of Sunitinib Malate Capsules. | ||
| NCT06456138 | Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC | ||
| NCT05646758 | A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects | ||
| NCT05735496 | Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers | ||
| NCT04216082 | A Study of Anlotinib in Subjects With Advanced Malignancy | ||
| NCT06230588 | A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | ||
| NCT03714568 | Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. | ||
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | ||
| NCT06962267 | A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) | ||
| NCT05110807 | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors | ||
| NCT04063683 | Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. | ||
| NCT03527888 | Study of Anlotinib in Patients With Primary Malignant Bone Tumors | ||
| NCT04439890 | A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer | ||
| NCT04964479 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | ||
| NCT06507891 | A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets | ||
| NCT05982106 | To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects |
